| 1 | Leukemia, T-Cell | 48.4% |
| 2 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 36% |
| 3 | Leukemia, Large Granular Lymphocytic | 36% |
| 4 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 36% |
| 5 | Lymphoma | 31.5% |
| 6 | Tumor Lysis Syndrome | 27.5% |
| 7 | Sezary Syndrome | 24.7% |
| 8 | Autoimmune Lymphoproliferative Syndrome | 22.5% |
| 9 | Leukemia, Plasma Cell | 22.2% |
| 10 | Composite Lymphoma | 21.4% |
| 11 | Infectious Mononucleosis | 21% |
| 12 | Hodgkin Disease | 20% |
| 13 | Lymphoma, Non-Hodgkin | 20% |
| 14 | Plasmacytoma | 19.6% |
| 15 | Lymphangioleiomyomatosis | 18.4% |
| 16 | Primary amyloidosis | 18.2% |
| 17 | Heavy Chain Disease | 17.4% |
| 18 | Sarcoidosis | 17.1% |
| 19 | Agammaglobulinemia | 16% |
| 20 | Histiocytic Disorders, Malignant | 15.9% |
| 21 | Waldenstrom Macroglobulinemia | 15.6% |
| 22 | Multiple Myeloma | 15.6% |
| 23 | Lymphoma, Follicular | 14.4% |
| 24 | T-Cell Lymphoma | 14.4% |
| 25 | Mantle cell lymphoma | 14.4% |
| 26 | Leukemia, Experimental | 14.3% |
| 27 | Granuloma | 13.9% |
| 28 | Lymphocele | 13.4% |
| 29 | Sarcoma, Myeloid | 12.9% |
| 30 | Lymphomatoid Granulomatosis | 12.5% |
| 31 | Adenitis | 12.4% |
| 32 | Histiocytosis | 12.4% |
| 33 | Lymphadenitis | 12.4% |
| 34 | Lymphangitis | 12.4% |
| 35 | Lymphedema | 12.4% |
| 36 | Neoplasms, Germ Cell and Embryonal | 12.4% |
| 37 | Neoplasms, Glandular and Epithelial | 12.4% |
| 38 | Splenic Diseases | 12.4% |
| 39 | Thymus Hyperplasia | 12.4% |
| 40 | Pseudolymphoma | 12.4% |
| 41 | Lymphadenopathy | 12.4% |
| 42 | Germ Cell Cancer | 12.4% |
| 43 | Leukemia, Radiation-Induced | 12.4% |
| 44 | Paraproteinemias | 11.9% |
| 45 | Thymus Neoplasms | 11.9% |
| 46 | Neuroectodermal Tumors | 11.8% |
| 47 | Lymphoma, T-Cell, Cutaneous | 11.7% |
| 48 | Lymphoma, AIDS-Related | 11.7% |
| 49 | Enteropathy-Associated T-Cell Lymphoma | 11.7% |
| 50 | Primary Effusion Lymphoma | 11.7% |
| 51 | Neoplasms, Neuroepithelial | 11.4% |
| 52 | Gliomatosis cerebri | 11.4% |
| 53 | Leukemia L1210 | 11% |
| 54 | Leukemia P388 | 11% |
| 55 | Thymoma | 10.9% |
| 56 | Mycosis Fungoides | 10.3% |
| 57 | Lymphomatoid Papulosis | 10.3% |
| 58 | Plasmablastic lymphoma | 10.3% |
| 59 | Leukemia, Myelomonocytic, Chronic | 10.3% |
| 60 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 10.3% |
| 61 | Monoclonal Gammopathy of Undetermined Significance | 10.2% |
| 62 | Lymphatic Abnormalities | 10.1% |
| 63 | Hypergammaglobulinemia | 10.1% |
| 64 | Lymphangiectasis, Intestinal | 9.8% |
| 65 | Carcinosarcoma | 9.7% |
| 66 | Hemangiosarcoma | 9.7% |
| 67 | Malignant histiocytosis | 9.7% |
| 68 | lymphangiosarcoma | 9.7% |
| 69 | Histiocytic sarcoma | 9.7% |
| 70 | melanoma | 9.7% |
| 71 | Transfusion Reaction | 9.7% |
| 72 | Hypotensive Transfusion Reaction | 9.7% |
| 73 | Splenic Neoplasms | 9.3% |
| 74 | Sarcoidosis, Pulmonary | 9.1% |
| 75 | Meningioma | 9% |
| 76 | Burkitt Lymphoma | 8.8% |
| 77 | Medulloblastoma | 8.5% |
| 78 | Carcinoma 256, Walker | 8.4% |
| 79 | Mucocutaneous Lymph Node Syndrome | 8.3% |
| 80 | Adenoma, Acidophil | 8% |
| 81 | Ganglioneuroma | 8% |
| 82 | Glioma | 8% |
| 83 | Malignant Glioma | 8% |
| 84 | Basal cell carcinoma | 7.7% |
| 85 | Carcinoma, Papillary | 7.7% |
| 86 | Squamous cell carcinoma | 7.7% |
| 87 | Chondrosarcoma | 7.7% |
| 88 | Craniopharyngioma | 7.7% |
| 89 | Cystadenoma | 7.7% |
| 90 | leiomyosarcoma | 7.7% |
| 91 | liposarcoma | 7.7% |
| 92 | Mesothelioma | 7.7% |
| 93 | synovial sarcoma | 7.7% |
| 94 | Neuroectodermal Tumor, Melanotic | 7.7% |
| 95 | Angiomyolipoma | 7.7% |
| 96 | Clear Cell Sarcoma of Soft Tissue | 7.7% |
| 97 | Alveolar Soft Part Sarcoma | 7.7% |
| 98 | Neuroendocrine Tumors | 7.7% |
| 99 | Carcinoma, Basal Cell | 7.7% |
| 100 | Trophoblastic Neoplasms | 7.7% |
| 101 | Autoimmune Diseases | 7.7% |
| 102 | Hamartoma | 7.7% |
| 103 | Hypersensitivity | 7.7% |
| 104 | Immunologic Deficiency Syndromes | 7.7% |
| 105 | Leukemia, Myeloid, Chronic-Phase | 7.7% |
| 106 | Neoplasms, Hormone-Dependent | 7.7% |
| 107 | Neoplasms, Multiple Primary | 7.7% |
| 108 | Paraneoplastic Syndromes | 7.7% |
| 109 | Precancerous Conditions | 7.7% |
| 110 | Neoplasms, Second Primary | 7.7% |
| 111 | Immune reconstitution syndrome | 7.7% |
| 112 | Immune Reconstitution Inflammatory Syndrome | 7.7% |
| 113 | Melanoma, Experimental | 7.5% |
| 114 | Adenoma | 7.3% |
| 115 | Ameloblastoma | 7.3% |
| 116 | Angiokeratoma | 7.3% |
| 117 | Carcinoma | 7.3% |
| 118 | Chordoma | 7.3% |
| 119 | Elephantiasis | 7.3% |
| 120 | Hemangioma | 7.3% |
| 121 | hemangiopericytoma | 7.3% |
| 122 | Hypersplenism | 7.3% |
| 123 | Lymphangioma | 7.3% |
| 124 | Mesenchymoma | 7.3% |
| 125 | Nevus | 7.3% |
| 126 | Teratoma | 7.3% |
| 127 | Hepatoblastoma | 7.3% |
| 128 | Mixed Tumor, Mullerian | 7.3% |
| 129 | Germinoma | 7.3% |
| 130 | Teratocarcinoma | 7.3% |
| 131 | Angiofibroma | 7.3% |
| 132 | Elephantiasis Nostras Verrucosa | 7.3% |
| 133 | Sarcoma | 7.3% |
| 134 | Epithelioma | 7.3% |
| 135 | Carcinoma, Ehrlich Tumor | 7.2% |
| 136 | Dermoid Cyst | 7.2% |
| 137 | Carcinoma, Lewis Lung | 7.2% |
| 138 | Carcinoid Tumor | 7.2% |
| 139 | Neurilemmoma | 7.2% |
| 140 | Hutchinson's Melanotic Freckle | 7.2% |
| 141 | Melanoma, Amelanotic | 7.2% |
| 142 | Cystadenocarcinoma | 6.8% |
| 143 | Fibrosarcoma | 6.8% |
| 144 | Osteosarcoma | 6.8% |
| 145 | Mucoepidermoid Carcinoma | 6.8% |
| 146 | Hematologic Neoplasms | 6.7% |
| 147 | Astrocytoma | 6.4% |
| 148 | Ependymoma | 6.4% |
| 149 | oligodendroglioma | 6.4% |
| 150 | Ganglioglioma | 6.4% |
| 151 | gliosarcoma | 6.4% |
| 152 | Anaplastic astrocytoma | 6.4% |
| 153 | Anaplastic Oligodendroglioma | 6.4% |
| 154 | Adenofibroma | 6.3% |
| 155 | Fibroadenoma | 6.3% |
| 156 | Malignant Fibrous Histiocytoma | 6.3% |
| 157 | Choriocarcinoma | 6.2% |
| 158 | Carcinoma, Lobular | 6.2% |
| 159 | Cyst | 6.2% |
| 160 | Neoplastic Processes | 6.2% |
| 161 | Neoplastic Syndromes, Hereditary | 6.2% |
| 162 | Pregnancy Complications, Neoplastic | 6.2% |
| 163 | Endometrial Stromal Sarcoma | 6.2% |
| 164 | Neoplasms, Experimental | 6.1% |
| 165 | Cryoglobulinemia | 6% |
| 166 | Sarcoma, Experimental | 6% |
| 167 | Malignant Carcinoid Syndrome | 6% |
| 168 | Splenic Infarction | 6% |
| 169 | Histiocytosis, Langerhans-Cell | 5.9% |
| 170 | Acanthoma | 5.8% |
| 171 | Bowen's Disease | 5.8% |
| 172 | Paraganglioma | 5.8% |
| 173 | Rhabdomyosarcoma | 5.8% |
| 174 | Giant Cell Tumor of Bone | 5.8% |
| 175 | Glioblastoma | 5.6% |
| 176 | Neuroblastoma | 5.6% |
| 177 | Glioblastoma Multiforme | 5.6% |
| 178 | Retinoblastoma | 5.6% |
| 179 | Multiple Endocrine Neoplasia | 5.5% |
| 180 | Dermatofibrosarcoma | 5.3% |
| 181 | Dermatofibrosarcoma Protuberans | 5.3% |
| 182 | Thrombocytopenic purpura | 5.2% |
| 183 | Ganglioneuroblastoma | 5.2% |
| 184 | Autoimmune thrombocytopenia | 5.2% |
| 185 | Immune thrombocytopenic purpura | 5.2% |
| 186 | POEMS Syndrome | 5.1% |
| 187 | Neoplasms, Radiation-Induced | 5.1% |
| 188 | Neurofibrosarcoma | 5.1% |
| 189 | Splenic Rupture | 5% |
| 190 | Glomerulonephritis, Membranoproliferative | 5% |
| 191 | Mastocytosis | 4.9% |
| 192 | Disseminated Intravascular Coagulation | 4.9% |
| 193 | Protein S Deficiency | 4.9% |
| 194 | Bone Marrow Neoplasms | 4.9% |
| 195 | Sarcoma 180 | 4.9% |
| 196 | Adenocarcinoma | 4.8% |
| 197 | Carcinoma in Situ | 4.8% |
| 198 | Carcinoma, Transitional Cell | 4.8% |
| 199 | Phyllodes Tumor | 4.8% |
| 200 | Dysgerminoma | 4.8% |
| 201 | Hemangioendothelioma | 4.8% |
| 202 | Lipoma | 4.8% |
| 203 | Lymphohistiocytosis, Hemophagocytic | 4.8% |
| 204 | Myoma | 4.8% |
| 205 | Myxoma | 4.8% |
| 206 | Neuroma | 4.8% |
| 207 | Papilloma | 4.8% |
| 208 | Pseudomyxoma Peritonei | 4.8% |
| 209 | Seminoma | 4.8% |
| 210 | Papillomatosis | 4.8% |
| 211 | Angiolipoma | 4.8% |
| 212 | Myelolipoma | 4.8% |
| 213 | Neoplasms, Bone Tissue | 4.8% |
| 214 | Neoplasms, Fibrous Tissue | 4.8% |
| 215 | Smooth Muscle Tumor | 4.8% |
| 216 | Adenomatosis, Pulmonary | 4.8% |
| 217 | Adenomatous Polyps | 4.8% |
| 218 | Carcinoma, Large Cell | 4.8% |
| 219 | Carcinoma, Small Cell | 4.8% |
| 220 | Desmoplastic Small Round Cell Tumor | 4.8% |
| 221 | Schnitzler Syndrome | 4.8% |
| 222 | Erdheim-Chester Disease | 4.8% |
| 223 | Chondroma | 4.8% |
| 224 | Enchondroma | 4.8% |
| 225 | Pheochromocytoma | 4.8% |
| 226 | Alveolar rhabdomyosarcoma | 4.8% |
| 227 | Carcinoid Heart Disease | 4.7% |
| 228 | Lymphopenia | 4.6% |
| 229 | Nephroblastoma | 4.6% |
| 230 | Paraneoplastic Encephalomyelitis | 4.5% |
| 231 | Thrombocythemia, Essential | 4.4% |
| 232 | Mammary Neoplasms, Experimental | 4.4% |
| 233 | Transfusion-Related Acute Lung Injury | 4.4% |
| 234 | Hemangioma, Cavernous | 4.3% |
| 235 | Basal Cell Nevus Syndrome | 4.2% |
| 236 | Tuberous Sclerosis | 4.2% |
| 237 | Mastocytosis, Systemic | 4.2% |
| 238 | Abdominal Neoplasms | 4.1% |
| 239 | Anemia | 4.1% |
| 240 | Blood Coagulation Disorders | 4.1% |
| 241 | Blood Platelet Disorders | 4.1% |
| 242 | Bone Marrow Diseases | 4.1% |
| 243 | Erythroplasia | 4.1% |
| 244 | Follicular cyst | 4.1% |
| 245 | Head and Neck Neoplasms | 4.1% |
| 246 | Hemorrhagic Disorders | 4.1% |
| 247 | Immune Complex Diseases | 4.1% |
| 248 | Leukocyte Disorders | 4.1% |
| 249 | Methemoglobinemia | 4.1% |
| 250 | Mucocele | 4.1% |
| 251 | Pancytopenia | 4.1% |
| 252 | Pilonidal Cyst | 4.1% |
| 253 | Polycythemia | 4.1% |
| 254 | Soft Tissue Neoplasms | 4.1% |
| 255 | Sulfhemoglobinemia | 4.1% |
| 256 | Thoracic Neoplasms | 4.1% |
| 257 | Thyroglossal Cyst | 4.1% |
| 258 | Antiphospholipid Syndrome | 4.1% |
| 259 | Synovial Cyst | 4.1% |
| 260 | Thrombophilia | 4.1% |
| 261 | Latex allergy | 4.1% |
| 262 | Erythrocytosis | 4.1% |
| 263 | Aberrant Crypt Foci | 4.1% |
| 264 | Acoustic Neuroma | 4% |
| 265 | Carcinoma, Pancreatic Ductal | 4% |
| 266 | Mesoblastic Nephroma | 3.8% |
| 267 | Thrombasthenia | 3.7% |
| 268 | Antithrombin III Deficiency | 3.7% |
| 269 | Protein C Deficiency | 3.7% |
| 270 | Hepatocellular Adenoma | 3.7% |
| 271 | Polycythemia Vera | 3.7% |
| 272 | Optic Nerve Glioma | 3.6% |
| 273 | Adenoid Cystic Carcinoma | 3.6% |
| 274 | fibroma | 3.6% |
| 275 | Fibromatosis | 3.6% |
| 276 | Osteoblastoma | 3.6% |
| 277 | Osteoma | 3.6% |
| 278 | Rhabdomyoma | 3.6% |
| 279 | Chondromatosis | 3.6% |
| 280 | Adenocarcinoma, Clear Cell | 3.6% |
| 281 | Cholangiocarcinoma | 3.6% |
| 282 | Cervical Intraepithelial Neoplasia | 3.6% |
| 283 | Hemangioblastoma | 3.6% |
| 284 | Lymphoma, Extranodal NK-T-Cell | 3.6% |
| 285 | Hydatidiform Mole | 3.5% |
| 286 | Digestive System Neoplasms | 3.4% |
| 287 | Endocrine Gland Neoplasms | 3.4% |
| 288 | Eye Neoplasms | 3.4% |
| 289 | Nervous System Neoplasms | 3.4% |
| 290 | Wiskott-Aldrich Syndrome | 3.4% |
| 291 | Environmental Illness | 3.4% |
| 292 | Vipoma | 3.4% |
| 293 | Bone neoplasms | 3.4% |
| 294 | Leukoplakia | 3.4% |
| 295 | Lupus Erythematosus, Systemic | 3.4% |
| 296 | Pancreatic Cyst | 3.4% |
| 297 | Pregnancy Complications, Hematologic | 3.4% |
| 298 | Skin Neoplasms | 3.4% |
| 299 | Overlap syndrome | 3.4% |
| 300 | Addison Disease | 3.3% |
| 301 | Barrett Esophagus | 3.3% |
| 302 | Breast Cyst | 3.3% |
| 303 | Actinic keratosis | 3.3% |
| 304 | Mediastinal Cyst | 3.3% |
| 305 | Neoplasm Invasiveness | 3.3% |
| 306 | Neoplasm Metastasis | 3.3% |
| 307 | Neoplasm Recurrence, Local | 3.3% |
| 308 | Parovarian Cyst | 3.3% |
| 309 | Pemphigus | 3.3% |
| 310 | Pericardial Cyst | 3.3% |
| 311 | Thymic Cyst | 3.3% |
| 312 | Carcinogenesis | 3.3% |
| 313 | Autoimmune thyroiditis | 3.3% |
| 314 | Myxoid cyst | 3.3% |
| 315 | Primary Adrenal Insufficiency | 3.3% |
| 316 | Metastasis | 3.3% |
| 317 | Sturge-Weber Syndrome | 3.3% |
| 318 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 3.3% |
| 319 | Autoimmune hepatitis | 3.3% |
| 320 | Eosinophilic Granuloma | 3.3% |
| 321 | Multiple Endocrine Neoplasia Type 1 | 3.3% |
| 322 | Splenosis | 3.3% |
| 323 | Gastrointestinal Stromal Tumors | 3.3% |
| 324 | Afibrinogenemia | 3.3% |
| 325 | Factor VII Deficiency | 3.3% |
| 326 | Factor X Deficiency | 3.3% |
| 327 | Factor XII Deficiency | 3.3% |
| 328 | Hemophilia A | 3.3% |
| 329 | Activated Protein C Resistance | 3.3% |
| 330 | Factor II deficiency | 3.3% |
| 331 | Factor VIII Deficiency | 3.3% |
| 332 | Factor V deficiency | 3.3% |
| 333 | Factor XI Deficiency | 3.3% |
| 334 | Hypoprothrombinemias | 3.3% |
| 335 | Vitamin K Deficiency | 3.3% |
| 336 | Thrombocytosis | 3.2% |
| 337 | Job Syndrome | 3.2% |
| 338 | Prolactinoma | 3.2% |
| 339 | Growth Hormone-Secreting Pituitary Adenoma | 3.2% |
| 340 | neurofibroma | 3.2% |
| 341 | Hydrops Fetalis | 3.1% |
| 342 | Fibromatosis, Aggressive | 3% |
| 343 | Fibromatosis, Abdominal | 3% |
| 344 | Klatskin Tumor | 3% |
| 345 | Kernicterus | 2.9% |
| 346 | Lambert-Eaton Myasthenic Syndrome | 2.9% |
| 347 | Mastocytoma | 2.9% |
| 348 | Adenomatous Polyposis Coli | 2.9% |
| 349 | Liver Neoplasms, Experimental | 2.9% |
| 350 | Parathyroid Neoplasms | 2.9% |
| 351 | Peritoneal Neoplasms | 2.9% |
| 352 | Thyroid Neoplasm | 2.9% |
| 353 | Thyroid carcinoma | 2.9% |
| 354 | granulosa cell tumor | 2.9% |
| 355 | Carcinoma, Ovarian Epithelial | 2.9% |
| 356 | Latent Autoimmune Diabetes in Adults | 2.8% |
| 357 | Dermatitis Herpetiformis | 2.8% |
| 358 | Kounis Syndrome | 2.8% |
| 359 | HIV Infections | 2.7% |
| 360 | Corpus Luteum Cyst | 2.7% |
| 361 | Ovarian Cysts | 2.7% |
| 362 | Chronic granulomatous disease | 2.7% |
| 363 | insulinoma | 2.7% |
| 364 | Hemoglobinuria, Paroxysmal | 2.6% |
| 365 | Leukemoid Reaction | 2.6% |
| 366 | Pancreatic Neoplasm | 2.5% |
| 367 | Asthma, Aspirin-Induced | 2.5% |
| 368 | anaphylaxis | 2.4% |
| 369 | Anemia, Hemolytic | 2.4% |
| 370 | Anemia, Macrocytic | 2.4% |
| 371 | Eosinophilia | 2.4% |
| 372 | Food Allergy | 2.4% |
| 373 | Hypoproteinemia | 2.4% |
| 374 | Leukopenia | 2.4% |
| 375 | Retroperitoneal Neoplasms | 2.4% |
| 376 | Thrombocytopenia | 2.4% |
| 377 | Leukostasis | 2.4% |
| 378 | MYELODYSPLASTIC SYNDROME | 2.4% |
| 379 | Anaphylactic shock | 2.4% |
| 380 | Adrenocortical carcinoma | 2.4% |
| 381 | Gastrinoma | 2.4% |
| 382 | Glucagonoma | 2.4% |
| 383 | Rheumatoid Arthritis | 2.4% |
| 384 | Choledochal Cyst | 2.4% |
| 385 | Juvenile arthritis | 2.4% |
| 386 | Tracheal Neoplasms | 2.4% |
| 387 | Graves Disease | 2.4% |
| 388 | Peutz-Jeghers Syndrome | 2.3% |
| 389 | Leukoplakia, Oral | 2.3% |
| 390 | Anti-Glomerular Basement Membrane Disease | 2.3% |
| 391 | Nasopharyngeal carcinoma | 2.3% |
| 392 | Paraneoplastic Cerebellar Degeneration | 2.3% |
| 393 | Serum Sickness | 2.3% |
| 394 | Leydig Cell Tumor | 2.3% |
| 395 | Purpura, Thrombotic Thrombocytopenic | 2.3% |
| 396 | Anemia, Diamond-Blackfan | 2.3% |
| 397 | Denys-Drash Syndrome | 2.2% |
| 398 | Renal Cell Carcinoma | 2.1% |
| 399 | Papillary Renal Cell Carcinoma | 2.1% |
| 400 | Anemia, Sickle Cell | 2.1% |
| 401 | Thalassemia | 2.1% |
| 402 | Myelitis, Transverse | 2.1% |
| 403 | Dupuytren Contracture | 2.1% |
| 404 | Esophageal Neoplasms | 2% |
| 405 | Respiratory Hypersensitivity | 2% |
| 406 | Carcinoma, Endometrioid | 2% |
| 407 | Limbic Encephalitis | 2% |
| 408 | Urticaria Pigmentosa | 2% |
| 409 | Anemia, Neonatal | 2% |
| 410 | Leukocytosis | 2% |
| 411 | Mouth Neoplasms | 2% |
| 412 | Pelger-Huet Anomaly | 2% |
| 413 | Sick Building Syndrome | 2% |
| 414 | Central Nervous System Neoplasms | 2% |
| 415 | Pleocytosis | 2% |
| 416 | Multiple Chemical Sensitivity | 2% |
| 417 | Vascular Neoplasms | 2% |
| 418 | Genital Neoplasms, Female | 2% |
| 419 | Pancreatic Pseudocyst | 2% |
| 420 | Urticaria | 2% |
| 421 | Vasculitis, Leukocytoclastic, Cutaneous | 2% |
| 422 | HTLV-I Infections | 1.9% |
| 423 | Lymphatic Metastasis | 1.9% |
| 424 | Neoplasms, Unknown Primary | 1.9% |
| 425 | Leukemic Infiltration | 1.9% |
| 426 | Breast Neoplasms, Male | 1.9% |
| 427 | Neoplasm Micrometastasis | 1.9% |
| 428 | Triple Negative Breast Neoplasms | 1.9% |
| 429 | Thyroid Nodule | 1.9% |
| 430 | Testicular Neoplasms | 1.8% |
| 431 | Adrenal Gland Neoplasms | 1.7% |
| 432 | Gastrointestinal Neoplasms | 1.7% |
| 433 | Genital Neoplasms, Male | 1.7% |
| 434 | Liver neoplasms | 1.7% |
| 435 | Uveal Neoplasms | 1.7% |
| 436 | Ataxia Telangiectasia | 1.7% |
| 437 | Myasthenia Gravis | 1.7% |
| 438 | Urologic Neoplasms | 1.7% |
| 439 | Uveomeningoencephalitic Syndrome | 1.7% |
| 440 | Opsoclonus-Myoclonus Syndrome | 1.7% |
| 441 | Drug Eruptions | 1.6% |
| 442 | Ecchymosis | 1.6% |
| 443 | Petechiae | 1.6% |
| 444 | Purpura | 1.6% |
| 445 | Sebaceous Gland Neoplasms | 1.6% |
| 446 | Spinal Neoplasms | 1.6% |
| 447 | Granulomatosis with polyangiitis | 1.6% |
| 448 | Dermatitis, Allergic Contact | 1.6% |
| 449 | Purpura, Hyperglobulinemic | 1.6% |
| 450 | HIV Seropositivity | 1.6% |
| 451 | Polycystic Ovary Syndrome | 1.6% |
| 452 | Primary Myelofibrosis | 1.6% |
| 453 | Agranulocytosis | 1.6% |
| 454 | Anemia, Megaloblastic | 1.6% |
| 455 | Lymphocytosis | 1.6% |
| 456 | Myelofibrosis | 1.6% |
| 457 | Myeloid Metaplasia | 1.6% |
| 458 | Milk Allergy | 1.6% |
| 459 | Hypoalbuminemia | 1.6% |
| 460 | Wheat Hypersensitivity | 1.6% |
| 461 | Hypereosinophilic syndrome | 1.6% |
| 462 | bone marrow fibrosis | 1.6% |
| 463 | Thrombotic Microangiopathies | 1.6% |
| 464 | Hemolytic-Uremic Syndrome | 1.6% |
| 465 | Xeroderma Pigmentosum | 1.5% |
| 466 | Sickle Cell Trait | 1.5% |
| 467 | Myasthenia Gravis, Autoimmune, Experimental | 1.4% |
| 468 | Stiff-Person Syndrome | 1.4% |
| 469 | Polyradiculoneuropathy | 1.4% |
| 470 | Polyradiculoneuritis | 1.4% |
| 471 | Acquired Immunodeficiency Syndrome | 1.4% |
| 472 | AIDS related complex | 1.4% |
| 473 | Felty Syndrome | 1.4% |
| 474 | Fanconi Anemia | 1.4% |
| 475 | Lupus Nephritis | 1.4% |
| 476 | Nose Neoplasms | 1.3% |
| 477 | Waterhouse-Friderichsen Syndrome | 1.3% |
| 478 | Meningeal Neoplasms | 1.3% |
| 479 | Palatal Neoplasms | 1.3% |
| 480 | Atypical Hemolytic Uremic Syndrome | 1.3% |
| 481 | AIDS-Related Opportunistic Infections | 1.2% |
| 482 | Vasculitis, Central Nervous System | 1.2% |
| 483 | Dermatitis, Atopic | 1.2% |
| 484 | ovarian neoplasm | 1.2% |
| 485 | Pituitary Adenoma | 1.2% |
| 486 | Pituitary Neoplasms | 1.2% |
| 487 | HIV Wasting Syndrome | 1.2% |
| 488 | Rheumatoid Vasculitis | 1.2% |
| 489 | AIDS Dementia Complex | 1.2% |
| 490 | AIDS-Associated Nephropathy | 1.2% |
| 491 | Neutropenia | 1.2% |
| 492 | Acute Chest Syndrome | 1.2% |
| 493 | Lupus Vasculitis, Central Nervous System | 1.2% |
| 494 | Ear Neoplasms | 1.1% |
| 495 | Eyelid Neoplasms | 1.1% |
| 496 | Lung Neoplasms | 1.1% |
| 497 | Pleural Neoplasms | 1.1% |
| 498 | Eosinophilia-Myalgia Syndrome | 1.1% |
| 499 | Niemann-Pick Disease, Type C | 1.1% |
| 500 | Angioedema | 1.1% |
| 501 | Cell Transformation, Viral | 1.1% |
| 502 | Brain Neoplasms | 1.1% |
| 503 | Multiple Sclerosis | 1.1% |
| 504 | Salivary Gland Neoplasms | 1.1% |
| 505 | Shwartzman Phenomenon | 1.1% |
| 506 | Spinal Cord Neoplasms | 1.1% |
| 507 | Tongue Neoplasms | 1.1% |
| 508 | Sicca Syndrome | 1.1% |
| 509 | Sjogren's Syndrome | 1.1% |
| 510 | HIV-Associated Lipodystrophy Syndrome | 1.1% |
| 511 | Scurvy | 1.1% |
| 512 | Uterine Neoplasms | 1.1% |
| 513 | Vaginal Neoplasms | 1.1% |
| 514 | Vulvar Neoplasms | 1.1% |
| 515 | Purpura Fulminans | 1.1% |
| 516 | Uterine Cancer | 1.1% |
| 517 | Acute Generalized Exanthematous Pustulosis | 1.1% |
| 518 | Fallopian Tube Neoplasms | 1.1% |
| 519 | Neuromyelitis Optica | 1% |
| 520 | Leukoencephalitis, Acute Hemorrhagic | 1% |
| 521 | Febrile Neutropenia | 1% |
| 522 | Pulmonary Eosinophilia | 1% |
| 523 | Eosinophilic Pneumonia | 1% |
| 524 | Zollinger-Ellison syndrome | 1% |
| 525 | Meningeal Carcinomatosis | 1% |
| 526 | Pharyngeal Neoplasms | 1% |
| 527 | Anemia, Pernicious | 1% |
| 528 | Asthma | 1% |
| 529 | Central Nervous System Cysts | 0.9% |
| 530 | Bile Duct Neoplasms | 0.9% |
| 531 | gallbladder neoplasm | 0.9% |
| 532 | Intestinal Neoplasms | 0.9% |
| 533 | Penile Neoplasms | 0.9% |
| 534 | Prostatic Neoplasms | 0.9% |
| 535 | Stomach Neoplasms | 0.9% |
| 536 | Encephalomyelitis, Acute Disseminated | 0.9% |
| 537 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.9% |
| 538 | Erythema Nodosum | 0.9% |
| 539 | Neuritis, Autoimmune, Experimental | 0.9% |
| 540 | Dermatitis, Photoallergic | 0.9% |
| 541 | Laryngeal neoplasm | 0.8% |
| 542 | Bronchial Neoplasms | 0.8% |
| 543 | Aspergillosis, Allergic Bronchopulmonary | 0.8% |
| 544 | Guillain-Barre Syndrome | 0.8% |
| 545 | Asthma, Exercise-Induced | 0.8% |
| 546 | Bladder Neoplasm | 0.8% |
| 547 | Kidney Neoplasm | 0.8% |
| 548 | Status Asthmaticus | 0.8% |
| 549 | Ureteral Neoplasms | 0.8% |
| 550 | Urethral Neoplasms | 0.8% |
| 551 | Multiple Pulmonary Nodules | 0.8% |
| 552 | Supratentorial Neoplasms | 0.8% |
| 553 | Multiple Sclerosis, Chronic Progressive | 0.8% |
| 554 | Multiple Sclerosis, Relapsing-Remitting | 0.8% |
| 555 | Endometrial Neoplasms | 0.8% |
| 556 | Toxic Epidermal Necrolysis | 0.7% |
| 557 | Stevens-Johnson Syndrome | 0.7% |
| 558 | Asthma, Occupational | 0.7% |
| 559 | Farmer's Lung | 0.7% |
| 560 | Angioedemas, Hereditary | 0.7% |
| 561 | Hypopharyngeal Neoplasms | 0.7% |
| 562 | Pleural Effusion, Malignant | 0.7% |
| 563 | Hypopharyngeal Cancer | 0.7% |
| 564 | Hay fever | 0.7% |
| 565 | Rhinitis, Allergic, Perennial | 0.7% |
| 566 | Parotid Neoplasms | 0.7% |
| 567 | Prostatic Neoplasms, Castration-Resistant | 0.7% |
| 568 | Nelson Syndrome | 0.7% |
| 569 | Hereditary Angioedema Type III | 0.7% |
| 570 | Hereditary Angioedema Types I and II | 0.7% |
| 571 | Brain Stem Neoplasms | 0.7% |
| 572 | Pseudoxanthoma Elasticum | 0.7% |
| 573 | Giant Cell Arteritis | 0.6% |
| 574 | Temporal Arteritis | 0.6% |
| 575 | Cecal Neoplasms | 0.6% |
| 576 | Duodenal Neoplasms | 0.6% |
| 577 | Choroid Plexus Papilloma | 0.6% |
| 578 | Tonsillar Neoplasms | 0.6% |
| 579 | Cerebellar Neoplasms | 0.6% |
| 580 | Nasopharyngeal Neoplasms | 0.5% |
| 581 | Colorectal Neoplasms | 0.5% |
| 582 | Radicular Cyst | 0.5% |
| 583 | Appendiceal Neoplasms | 0.5% |
| 584 | Colonic Neoplasms | 0.5% |
| 585 | Rectal Neoplasms | 0.5% |
| 586 | Paranasal Sinus Neoplasms | 0.5% |
| 587 | Miller Fisher Syndrome | 0.4% |
| 588 | Maxillary Sinus Neoplasms | 0.4% |
| 589 | Anus Neoplasms | 0.4% |
| 590 | Sigmoid Neoplasms | 0.4% |